iSirona Signs Reference Selling Agreement with NxStage

Share Article

Relationship Expected to Result in Improved Nursing Productivity in the Treatment of Renal Disease

Not only will this functionality ensure that the data is documented to the correct patient, it will improve the speed and accuracy of data available for clinical review and decision making.

iSirona®, an innovative provider of data automation solutions for healthcare providers, today announced that it has signed an agreement with NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products. Under the agreement, iSirona will develop the iSirona Gateway for the NxStage System One™ renal dialysis system.

The iSirona gateway is being developed to allow NxStage customers to integrate critical data from their NxStage products into their hospital information systems. Once completed, the gateway will allow critical care facilities to leverage the NxStage System One's robust data collection capabilities and take advantage of iSirona's proprietary Positive Patient Identification logic. This will ensure that patient data retrieved from a device is accurately linked to the correct patient.

"The NxStage System One is a robust and innovative solution, offering treatment flexibility and ease of use to caregivers in the critical care setting," states Jeffrey H. Burbank, CEO of NxStage Medical, Inc. "We look forward to working with iSirona with the goal of delivering increased return on investment and benefits to System One customers within the critical care market."

"We are excited to work with NxStage in delivering connectivity between the System One and clinical information systems such as the EMR," says Peter Witonsky, iSirona's president and chief sales officer. "Not only will this functionality ensure that the data is documented to the correct patient, it will improve the speed and accuracy of data available for clinical review and decision making."

About NxStage Medical:
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company headquartered in Lawrence, Massachusetts that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.

About iSirona:
Panama City, Florida-based iSirona (http://www.isirona.com) develops clinical automation solutions for healthcare. The iSirona Enterprise™ product suite delivers medical device data from bedside and mobile devices to clinical information systems, simplifying the process of patient data collection. iSirona accelerates return-on-investment by streamlining workflow and maximizing IT investments. Uniquely positioned to deliver the most robust solution, iSirona guarantees delivery of accurate, timely and complete patient data.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jene Leiner
isirona
651-330-1724
Email >

Kristen Sheppard
NxStage
978-332-5923
Email >
Visit website